Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease

BACKGROUND: Increased circulatory levels of the chemokine CXCL4 have been associated with the presence of interstitial lung disease (ILD) in an observational study of patients with systemic sclerosis (SSc). The purpose of the present study was to evaluate the relationship between baseline CXCL4 leve...

Descripción completa

Detalles Bibliográficos
Autores principales: Volkmann, Elizabeth R., Tashkin, Donald P., Roth, Michael D., Clements, Philip J., Khanna, Dinesh, Furst, Daniel E., Mayes, Maureen, Charles, Julio, Tseng, Chi-Hong, Elashoff, Robert M., Assassi, Shervin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203703/
https://www.ncbi.nlm.nih.gov/pubmed/28038680
http://dx.doi.org/10.1186/s13075-016-1203-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203703/
https://www.ncbi.nlm.nih.gov/pubmed/28038680
http://dx.doi.org/10.1186/s13075-016-1203-y

Ejemplares similares